This wiki has undergone a migration to Confluence found Here
Difference between revisions of "20180316 PLA call"
Jump to navigation
Jump to search
Line 12: | Line 12: | ||
========================================================================---> | ========================================================================---> | ||
| colspan="2" align="left" style="background:#f0f0f0;"|'''HL7 PLA Call Minutes''' <br/> | | colspan="2" align="left" style="background:#f0f0f0;"|'''HL7 PLA Call Minutes''' <br/> | ||
− | '''Location: ''' Phone: | + | '''Location: ''' Phone: <br/>https://global.gotomeeting.com/join/177894709 |
| colspan="2" align="left" style="background:#f0f0f0;"|'''Date: 2018-03-16'''<br/> '''Time: 11:30 AM''' | | colspan="2" align="left" style="background:#f0f0f0;"|'''Date: 2018-03-16'''<br/> '''Time: 11:30 AM''' | ||
|- | |- |
Revision as of 15:29, 16 March 2018
return to HL7 Product Line Architecture Meeting Minutes and Agendas
Return to HL7 Product Line Architecture Program
HL7 PLA Call Minutes Location: Phone: |
Date: 2018-03-16 Time: 11:30 AM | ||
Facilitator | Mary Kay/ Austin | Note taker(s) | Anne |
Attendee | Name
| ||
Calvin Beebe | |||
Lorraine Constable | |||
Jean Duteau, | |||
Tony Julian | |||
Paul Knapp | |||
Austin Kreisler, | |||
Mary Kay McDaniel | |||
Brian Pech | |||
Wayne Kubick | |||
John Roberts | |||
Andy Stechishin | |||
no quorum definition |
Agenda
Agenda review
- Notes of 20180302_PLA_call review
- Actions
- Anne to forward V2MG mission and charter to SGB for review
- Brian to draft email to solicit volunteers
- Discussion
- CIMI-MG Candidates
- notional division of products into product families and lines, to provide examples for peer review.
- Level of granularity
- Identify which pieces are orphaned, and the political elements to be surfaced.
- Positioning cross-product family artifacts (standards naming)
- BAM-lite feedback and review
- Governance on V2.x (v2.9 substantive changes)
- develop form to request establishing a Product Family
Minutes
Convened
Adjourned
Meeting Outcomes
Actions
|
Next Meeting/Preliminary Agenda Items |
© 2017 Health Level Seven® International. All rights reserved